Episode
Sabina Hemmi - The GLP-1 Wars
- Podcast
- Hims House
- Published
- Feb 3, 2026
- Duration seconds
- 3552
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/sabina-hemmi-the-glp-1-wars/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hims-house-7026583/sabina-hemmi-the-glp-1-wars.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Thanks to our partner, Mochi Health! https://JoinMochi.com In this episode of Hims House, Jonathan Stern sits down with Sabina Hemmi (founder of GLP Winner), for the most comprehensive episode on GLP-1s that Hims House has done. They cover the compounding wars -- federal legislation, state-level crackdowns, and the lawsuits -- before diving into why tirzepatide dominates patient demand and what might be holding Hims back from offering it. The discussion spans oral GLP-1s, microdosing trends, and concludes with Sabina's skeptical take on peptides. 00:00 - Sponsor: Mochi Health 02:59 - Video games → GLP-1s 04:56 - GLP Winner Overview 10:28 - Who does Hims actually compete with? 16:43 - Hims x Novo Relationship 23:17 - Why tirzepatide is superior 29:30 - The SAFE Drugs Act 32:23 - State Bills: Indiana, Florida, Virginia 40:43 - Adverse events 43:09 - GLP-1 pill vs. injectables 50:57 - Over-the-Counter GLP-1 coming soon? 52:55 - Peptides Not financial, legal, or medical advice Subscribe to Hims House: https://himshouse.com/subscribe Follow Sabina: Tiktok: https://www.tiktok.com/@lawliepop Instagram: https://www.instagram.com/lawliepops Youtube: https://www.youtube.com/@lawliepop X/Twitter: https://x.com/lawliepop Substack: https://substack.com/@lawliepop Linkedin: https://www.linkedin.com/in/sabina-hemmi Follow us: https://x.com/himshouse https://x.com/jonathanrstern Join the Discord: https://discord.gg/tJqGgVhkEt